Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 201–300 of 1,018
Caccamo, A., Majumder, S., Deng, J. J., Bai, Y., Thornton, F. B., & Oddo, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031278 · Cited by 169
Progranulin in neurodegenerative disease
Petkau, T. L., & Leavitt, B. R. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.04.003 · Cited by 169
Youn, B.-S., Bang, S.-I., Klöting, N., Park, J. W., Lee, N., Oh, J.-E., Pi, K.-B., Lee, T. H., Ruschke, K., Fasshauer, M., et al. (2009) · Diabetes · doi:10.2337/db08-1147 · Cited by 169
Autophagy induction by trehalose: Molecular mechanisms and therapeutic impacts
Hosseinpour‐Moghaddam, K., Caraglia, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26583 · Cited by 168
Genetics of sporadic amyotrophic lateral sclerosis
Schymick, J. C., Talbot, K., & Traynor, B. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm215 · Cited by 169
van der Zee, J., Urwin, H., Engelborghs, S., Bruyland, M., Vandenberghe, R., Dermaut, B., De Pooter, T., Peeters, K., Santens, P., De Deyn, P. P., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm309 · Cited by 167
Frontotemporal dementia and related disorders: Deciphering the enigma
Josephs, K. A. (2008) · Annals of Neurology · doi:10.1002/ana.21426 · Cited by 166
Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease
Brouwers, N., Sleegers, K., Engelborghs, S., Maurer-Stroh, S., Gijselinck, I., van der Zee, J., Pickut, B. A., Van den Broeck, M., Mattheijssens, M., Peeters, K., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000319688.89790.7a · Cited by 166
Innate immune activation in neurodegenerative diseases
Castro-Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 162
TDP-43 in aging and Alzheimer's disease - a review.
Wilson, A. C., Dugger, B. N., Dickson, D. W., & Wang, D.-S. (2011) · PubMed Central · Cited by 199
Self-citationZhan, L., Krabbe, G., Du, F., Jones, I., Reichert, M. C., Telpoukhovskaia, M., Kodama, L., Wang, C., Cho, S.-H., Sayed, F., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000134 · Cited by 163
Progranulin null mutations in both sporadic and familial frontotemporal dementia
Le Ber, I., van der Zee, J., Hannequin, D., Gijselinck, I., Campion, D., Puel, M., Laquerrière, A., De Pooter, T., Camuzat, A., Van den Broeck, M., et al. (2007) · Human Mutation · doi:10.1002/humu.20520 · Cited by 164
Lang, C. M., Fellerer, K., Schwenk, B. M., Kuhn, P.-H., Kremmer, E., Edbauer, D., Capell, A., & Haass, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365098 · Cited by 162
Foulds, P., McAuley, E., Gibbons, L., Davidson, Y., Pickering-Brown, S. M., Neary, D., Snowden, J. S., Allsop, D., & Mann, D. M. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0389-8 · Cited by 162
Self-citationProgranulin genetic variability contributes to amyotrophic lateral sclerosis
Sleegers, K., Brouwers, N., Maurer-Stroh, S., van Es, M. A., Damme, P. V., van Vught, P. W. J., van der Zee, J., Serneels, S., Pooter, T. D., Van den Broeck, M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000289191.54852.75 · Cited by 161
Gitcho, M. A., Bigio, E. H., Mishra, M., Johnson, N., Weintraub, S., Mesulam, M., Rademakers, R., Chakraverty, S., Cruchaga, C., Morris, J. C., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0571-7 · Cited by 161
Self-citationRNA-binding proteins with prion-like domains in ALS and FTLD-U
Gitler, A. D., & Shorter, J. (2011) · Prion · doi:10.4161/pri.5.3.17230 · Cited by 161
Progranulin is expressed within motor neurons and promotes neuronal cell survival
Ryan, C. L., Baranowski, D. C., Chitramuthu, B. P., Malik, S., Li, Z., Cao, M., Minotti, S., Durham, H. D., Kay, D. G., Shaw, C. A., et al. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-130 · Cited by 160
Tolkatchev, D., Malik, S., Vinogradova, A., Wang, P., Chen, Z., Xu, P., Bennett, H. P. J., Bateman, A., & Ni, F. (2008) · Protein Science · doi:10.1110/ps.073295308 · Cited by 160
Progranulin Mutations in Primary Progressive Aphasia: The PPA1 and PPA3 Families
Mesulam, M., Johnson, N., Krefft, T. A., Gass, J. M., Cannon, A. D., Adamson, J. L., Bigio, E. H., Weintraub, S., Dickson, D. W., Hutton, M. L., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.43 · Cited by 160
Self-citationTDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
Arseni, D., Chen, R., Murzin, A. G., Peak-Chew, S. Y., Garringer, H. J., Newell, K. L., Kametani, F., Robinson, A. C., Vidal, R., Ghetti, B., et al. (2023) · Nature · doi:10.1038/s41586-023-06405-w · Cited by 156
“New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)
Nelson, P. T., Trojanowski, J. Q., Abner, E. L., Al-Janabi, O. M., Jicha, G. A., Schmitt, F. A., Smith, C. D., Fardo, D. W., Wang, W.-X., Kryscio, R. J., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw033 · Cited by 158
Progranulin regulates neuronal outgrowth independent of Sortilin
Gass, J., Lee, W. C., Cook, C., Finch, N., Stetler, C., Jansen-West, K., Lewis, J., Link, C. D., Rademakers, R., Nykjær, A., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-33 · Cited by 156
Self-citationProgranulin protects against osteoarthritis through interacting with TNF-α and β-Catenin signalling
Zhao, Y., Liu, B., Tian, Q., Wei, J.-L., Richbourgh, B., & Liu, C.-J. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205779 · Cited by 161
Dormann, D., Capell, A., Carlson, A. M., Shankaran, S. S., Rodde, R., Neumann, M., Kremmer, E., Matsuwaki, T., Yamanouchi, K., Nishihara, M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06211.x · Cited by 156
Tanaka, Y., CHAMBERS, J. K., Matsuwaki, T., Yamanouchi, K., & Nishihara, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/preaccept-4589926441299369 · Cited by 156
Genetics of Frontotemporal Dementia
Olszewska, D. A., Lonergan, R., Fallon, E., & Lynch, T. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0707-9 · Cited by 194
Arrant, A. E., Onyilo, V. C., Unger, D. E., & Roberson, E. D. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.3081-17.2018 · Cited by 156
Frontotemporal dementia and motor neurone disease: Overlapping clinic-pathological disorders
Lillo, P., & Hodges, J. R. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.03.005 · Cited by 195
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia
van Blitterswijk, M., Mullen, B., Nicholson, A. M., Bieniek, K. F., Heckman, M. G., Baker, M. C., DeJesus-Hernandez, M., Finch, N. A., Brown, P. H., Murray, M. E., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1240-4 · Cited by 154
Self-citationTanaka, Y., Matsuwaki, T., Yamanouchi, K., & Nishihara, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.049 · Cited by 163
Ince, P. G., Highley, J. R., Kirby, J., Wharton, S. B., Takahashi, H., Strong, M. J., & Shaw, P. J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0913-0 · Cited by 171
Progranulin expression in the developing and adult murine brain
Petkau, T. L., Neal, S. J., Orban, P. C., MacDonald, J. L., Hill, A. M., Lu, G., Feldman, H. H., Mackenzie, I. R. A., & Leavitt, B. R. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22430 · Cited by 152
“Given that one of the core pathological features of FTLD is prominent gliosis (Baker et al., 2006), it is unlikely that the heterozygous loss of GRN, as occurs in patients, causes a major impairment to microglia migration.”
BackgroundSelf-citationFrontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype
Mann, D. M. A., & Snowden, J. S. (2017) · Brain Pathology · doi:10.1111/bpa.12486 · Cited by 153
Self-citationFrontotemporal Dementia: Implications for Understanding Alzheimer Disease
Goedert, M., Ghetti, B., & Spillantini, M. G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006254 · Cited by 152
Primary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration
Neher, J. J., Neniskyte, U., & Brown, G. C. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00027 · Cited by 152
Brouwers, N., Nuytemans, K., van der Zee, J., Gijselinck, I., Engelborghs, S., Theuns, J., Kumar-Singh, S., Pickut, B. A., Pals, P., Dermaut, B., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.1436 · Cited by 150
Invited Review: The role of prion‐like mechanisms in neurodegenerative diseases
Jaunmuktane, Z., & Brandner, S. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12592 · Cited by 150
Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases
Chang, A., Xiang, X., Wang, J., Lee, C., Arakhamia, T., Simjanoska, M., Wang, C., Carlomagno, Y., Zhang, G., Dhingra, S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.026 · Cited by 150
Self-citationFrontotemporal Dementia: diagnosis, Deficits and Management
Bott, N. T., Radke, A., Stephens, M. L., & Kramer, J. H. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.34 · Cited by 149
Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription
Cenik, B., Sephton, C. F., Dewey, C. M., Xian, X., Wei, S., Yu, K., Niu, W., Coppola, G., Coughlin, S. E., Lee, S. E., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193433 · Cited by 147
Genetics of FTLD : overview and what else we can expect from genetic studies
Pottier, C., Ravenscroft, T. A., Sanchez‐Contreras, M., & Rademakers, R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13622 · Cited by 148
Self-citationThe clinical spectrum of sporadic and familial forms of frontotemporal dementia
Woollacott, I. O. C., & Rohrer, J. D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13654 · Cited by 149
The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis
Strong, M. J. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802372371 · Cited by 148
Boeve, B. F., & Hutton, M. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.460 · Cited by 148
Self-citationC9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Lall, D., Lorenzini, I., Mota, T. A., Bell, S., Mahan, T. E., Ulrich, J. D., Davtyan, H., Rexach, J. E., Muhammad, A. K. M. G., Shelest, O., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.020 · Cited by 147
Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy
Laird, A. S., Van Hoecke, A., De Muynck, L., Timmers, M., Van Den Bosch, L., Van Damme, P., & Robberecht, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013368 · Cited by 147
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
Forrest, S. L., Kril, J. J., Stevens, C. H., Kwok, J. B., Hallupp, M., Kim, W. S., Huang, Y., McGinley, C. V., Werka, H., Kiernan, M. C., et al. (2018) · Brain · doi:10.1093/brain/awx328 · Cited by 148
Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo
Beel, S., Moisse, M., Damme, M., De Muynck, L., Robberecht, W., Van Den Bosch, L., Saftig, P., & Van Damme, P. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx162 · Cited by 146
Review: neuropathology of non-tau frontotemporal lobar degeneration
Neumann, M., & Mackenzie, I. R. A. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12526 · Cited by 144
Self-citationMechanisms of toxicity in C9FTLD/ALS
Gendron, T. F., Belzil, V. V., Zhang, Y.-J., & Petrucelli, L. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1237-z · Cited by 145
Valdez, C., Wong, Y. C., Schwake, M., Bu, G., Wszolek, Z. K., & Krainc, D. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx364 · Cited by 143
Progranulin: normal function and role in neurodegeneration
Eriksen, J. L., & Mackenzie, I. R. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04968.x · Cited by 144
Self-citationALS and FTLD: two faces of TDP‐43 proteinopathy
Liscic, R. M., Grinberg, L. T., Zidar, J., Gitcho, M. A., & Cairns, N. J. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02195.x · Cited by 143
Development and Validation of Pedigree Classification Criteria for Frontotemporal Lobar Degeneration
Wood, E. M., Falcone, D., Suh, E., Irwin, D. J., Chen-Plotkin, A. S., Lee, E. B., Xie, S. X., Van Deerlin, V. M., & Grossman, M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3956 · Cited by 143
Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation
Chang, M. C., Srinivasan, K., Friedman, B. A., Suto, E., Modrusan, Z., Lee, W. P., Kaminker, J. S., Hansen, D. V., & Sheng, M. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160999 · Cited by 141
Cheung, S., Cheung, P. F., Cheng, C. K. C., Wong, N. C. L., & Fan, S. T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.049 · Cited by 142
Relationships between Stress Granules, Oxidative Stress, and Neurodegenerative Diseases
Chen, L., & Liu, B. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1809592 · Cited by 139
The neuropathology and clinical phenotype of FTD with progranulin mutations
Mackenzie, I. R. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0223-8 · Cited by 141
Self-citationLobsiger, C. S., Boillée, S., & Cleveland, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702230104 · Cited by 140
Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., Geschwind, M. D., Tartaglia, M. C., Gao, F., Gianni, D., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.007 · Cited by 140
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders
Janssens, J., & Van Broeckhoven, C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt349 · Cited by 139
Back to the tubule: microtubule dynamics in Parkinson’s disease
Pellegrini, L., Wetzel, A., Grannó, S., Heaton, G., & Harvey, K. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2351-6 · Cited by 137
Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease
Chitramuthu, B. P., Bennett, H. P. J., & Bateman, A. (2017) · Brain · doi:10.1093/brain/awx198 · Cited by 138
“Loss of one allele of GRN, the gene encoding progranulin, leads to the development of frontotemporal dementia (FTD) (Baker et al., 2006; Cruts et al., 2006).”
BackgroundCarrasquillo, M. M., Nicholson, A. M., Finch, N., Gibbs, J. R., Baker, M., Rutherford, N. J., Hunter, T. A., DeJesus-Hernandez, M., Bisceglio, G. D., Mackenzie, I. R., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.002 · Cited by 130
Self-citationGuo, F., Lai, Y., Tian, Q., Lin, E. A., Kong, L., & Liu, C. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27491 · Cited by 138
Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research
Wray, S., Self, M., NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC Consortium, Lewis, P. A., Taanman, J.-W., Ryan, N. S., Mahoney, C. J., Liang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043099 · Cited by 138
Self-citationTargeted manipulation of the sortilin–progranulin axis rescues progranulin haploinsufficiency
Lee, W. C., Almeida, S., Prudencio, M., Caulfield, T. R., Zhang, Y.-J., Tay, W. M., Bauer, P. O., Chew, J., Sasaguri, H., Jansen-West, K. R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt534 · Cited by 125
Self-citationStribl, C., Samara, A., Trümbach, D., Peis, R., Neumann, M., Fuchs, H., Gailus-Durner, V., Hrabě de Angelis, M., Rathkolb, B., Wolf, E., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515940 · Cited by 136
Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia
Fratta, P., Poulter, M., Lashley, T., Rohrer, J. D., Polke, J. M., Beck, J., Ryan, N., Hensman, D., Mizielinska, S., Waite, A. J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1147-0 · Cited by 137
Suh, H.-S., Choi, N., Tarassishin, L., & Lee, S. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035115 · Cited by 137
A Reassessment of the Neuropathology of Frontotemporal Dementia Linked to Chromosome 3
Holm, I. E., Englund, E., Mackenzie, I. R. A., Johannsen, P., & Isaacs, A. M. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181567f02 · Cited by 137
Self-citationLipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency
Evers, B. M., Rodriguez-Navas, C., Tesla, R. J., Prange-Kiel, J., Wasser, C. R., Yoo, K. S., McDonald, J., Cenik, B., Ravenscroft, T. A., Plattner, F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.056 · Cited by 137
Self-citationThe Role of Neuroinflammation in Dementias
Pasqualetti, G., Brooks, D. J., & Edison, P. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0531-7 · Cited by 133
Chen-Plotkin, A. S., Geser, F., Plotkin, J. B., Clark, C. M., Kwong, L. K., Yuan, W., Grossman, M., Van Deerlin, V. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn023 · Cited by 135
Holler, C. J., Taylor, G., Deng, Q., & Kukar, T. (2017) · eneuro · doi:10.1523/eneuro.0100-17.2017 · Cited by 136
Egashira, Y., Suzuki, Y., Azuma, Y., Takagi, T., Mishiro, K., Sugitani, S., Tsuruma, K., Shimazawa, M., Yoshimura, S., Kashimata, M., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-105 · Cited by 135
CDC7 inhibition blocks pathological TDP‐43 phosphorylation and neurodegeneration
Liachko, N. F., McMillan, P. J., Guthrie, C. R., Bird, T. D., Leverenz, J. B., & Kraemer, B. C. (2013) · Annals of Neurology · doi:10.1002/ana.23870 · Cited by 143
Schymick, J. C., Yang, Y., Andersen, P. M., Vonsattel, J. P., Greenway, M., Momeni, P., Elder, J., Chio, A., Restagno, G., Robberecht, W., et al. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.109553 · Cited by 134
Self-citationGijselinck, I., Van Broeckhoven, C., & Cruts, M. (2008) · Human Mutation · doi:10.1002/humu.20785 · Cited by 133
Progranulin Mutations as Risk Factors for Alzheimer Disease
Perry, D. C., Lehmann, M., Yokoyama, J. S., Karydas, A., Lee, J. J., Coppola, G., Grinberg, L. T., Geschwind, D., Seeley, W. W., Miller, B. L., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.393 · Cited by 133
Krabbe, G., Minami, S. S., Etchegaray, J. I., Taneja, P., Djukic, B., Davalos, D., Le, D., Lo, I., Zhan, L., Reichert, M. C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700477114 · Cited by 132
The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
Kawakami, I., Arai, T., & Hasegawa, M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02077-x · Cited by 132
Progranulin: A growth factor, a novel TNFR ligand and a drug target
Liu, C.-J., & Bosch, X. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.003 · Cited by 133
Frontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management
Seltman, R. E., & Matthews, B. R. (2012) · CNS Drugs · doi:10.2165/11640070-000000000-00000 · Cited by 132
Capell, A., Liebscher, S., Fellerer, K., Brouwers, N., Willem, M., Lammich, S., Gijselinck, I., Bittner, T., Carlson, A. M., Sasse, F., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5757-10.2011 · Cited by 132
EphA2 is a functional receptor for the growth factor progranulin
Neill, T., Buraschi, S., Goyal, A., Sharpe, C., Natkanski, E., Schaefer, L., Morrione, A., & Iozzo, R. V. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201603079 · Cited by 131
Arai, T., Hasegawa, M., Nonoka, T., Kametani, F., Yamashita, M., Hosokawa, M., Niizato, K., Tsuchiya, K., Kobayashi, Z., Ikeda, K., et al. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2009.01089.x · Cited by 131
Pottier, C., Zhou, X., Perkerson, R. B., Baker, M., Jenkins, G. D., Serie, D. J., Ghidoni, R., Benussi, L., Binetti, G., López de Munain, A., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30126-1 · Cited by 131
Self-citationCommon Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Weishaupt, J. H., Hyman, T., & Đikić, I. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.005 · Cited by 147
Götzl, J. K., Brendel, M., Werner, G., Parhizkar, S., Sebastian Monasor, L., Kleinberger, G., Colombo, A., Deussing, M., Wagner, M., Winkelmann, J., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809711 · Cited by 118
Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.
van Eersel, J., Ke, Y. D., Gladbach, A., Bi, M., Götz, J., Kril, J. J., & Ittner, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022850 · Cited by 130
Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β
Gao, X., Joselin, A. P., Wang, L., Kar, A., Ray, P., Bateman, A., Goate, A. M., & Wu, J. Y. (2010) · Protein & Cell · doi:10.1007/s13238-010-0067-1 · Cited by 128
TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Broeck, L. V., Callaerts, P., & Dermaut, B. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.003 · Cited by 147
Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing
Neltner, J. H., Abner, E. L., Baker, S., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Smith, C. D., Hammack, E., Kukull, W. A., Brenowitz, W. D., et al. (2014) · Brain · doi:10.1093/brain/awt318 · Cited by 131
Zhou, X., Sun, L., Bracko, O., Choi, J. W., Jia, Y., Nana, A. L., Brady, O. A., Hernandez, J. C. C., Nishimura, N., Seeley, W. W., et al. (2017) · Nature Communications · doi:10.1038/ncomms15277 · Cited by 128
Leverenz, J. B., Yu, C. E., Montine, T. J., Steinbart, E., Bekris, L. M., Zabetian, C., Kwong, L. K., Lee, V. M.-Y., Schellenberg, G. D., & Bird, T. D. (2007) · Brain · doi:10.1093/brain/awm069 · Cited by 129
Rosen, E. Y., Wexler, E. M., Versano, R., Coppola, G., Gao, F., Winden, K. D., Oldham, M. C., Martens, L. H., Zhou, P., Farese, R. V., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.021 · Cited by 128
Lu, Y., Ferris, J., & Gao, F.-B. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-30 · Cited by 128
Synaptic Pruning by Microglia in Epilepsy
Andoh, M., Ikegaya, Y., & Koyama, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122170 · Cited by 127
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.